LAV4HD AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−330k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−255k kr).
LAV4HD AS is registered as a limited company in Kristiansand, Agder with organisation number 933769917. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2024. Registered share capital is NOK 33,000, divided into 33333 shares. The company's stated purpose is: “Finansiering og utvikling av medisin mot Huntington Disease. Selskapet innehar alle kommersielle rettigheter for en fremtidig medisin som kan stoppe utviklingen av Huntington-sykdommen hos mennesker. Proteinet er ferdig utviklet og testet på mus - med svært lovende resultater. Neste fase er å avsjekke at proteinet ikke har uheldige bivirkninger på mennesker.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −255,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns LAV4HD AS?
LAV4HD AS has 6 registered shareholders:
- SUMATRA AS 27.0%
- SVEIN OLAF OLSEN 17.1%
- Stein Olaf Lund 16.2%
- INVEST CORPORATE AS 16.2%
- THE INTERNATIONAL HUNTINGTON ASSOCIATION NORWAY 13.5%
- DIGITAL LICENSE RETAILER AS 10.0%
Frequently asked questions about LAV4HD AS
Who owns LAV4HD AS?
SUMATRA AS is the largest registered owner, with 27.0%.
What is the revenue of LAV4HD AS?
LAV4HD AS had revenue of NOK 0 in 2025.
Who is the general manager of LAV4HD AS?
Svein Olaf Olsen is registered as general manager of LAV4HD AS.
Where is LAV4HD AS based?
LAV4HD AS has its business address in Kristiansand S.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.